Treatments for alcohol misuse Flashcards
Indications for inpatient alcohol detoxification instead of outpatient
Past or current DTs
Past or current seizures
Psychiatric morbidity with risk of suicide
Poor physical health
Wernicke’s or Korsakoff’s
Homelessness
Social situation where outpatient detox might not be completed successfully
Most suitable benzodiazepines for alcohol detox in a patient with liver failure
Lorazepam
Oxazepam
Reason why lorazepam or oxazepam are more suitable for alcohol detox in patients with liver failure
They do not have phase 1 metabolism
Description of front loading benzodiazepine detox regime
Loading dose of diazepam is given
Further doses are given every 90 minutes until the patient is lightly sedated
No further medication is given
The long half life of diazepam covers the withdrawal
Disadvantages of using chlormethiazole for an alcohol detox
Variable oral bioavailability
Higher risk of respiratory depression
Higher addictive potential
Higher street value
Mechanism of action of acamprosate
Inhibits glutamatergic NMDA receptor function
Balances the GABA glutamate imbalance seen in alcoholism
Most common side effects with acamprosate
GI disturbance
Number needed to treat with acamprosate to prevent one relapse
11
Mechanism of action of naltrexone
Opioid antagonist
Mechanism of action of nalmefene
Opioid receptor modulator
Benefits to prescribing nalmefene against other medications used to prevent relapse of alcohol abuse
Can be prescribed PRN
No requirement for blood monitoring
Can be used in a community setting
Mechanism of action of disulfiram
Blocks aldehyde dehydrogenase, results in the accumulation of acetaldehyde leading to signs and symptoms of nausea, vomiting, headache etc. if alcohol is drunk
Contraindications to disulfiram
Impulsivity
Suicidality
Psychosis
Severe hepatic dysfunction
Peripheral neuropathy
Cardiac disease
Treatments included in the Project MATCH study
CBT
Twelve step programme
Motivational enhancement therapy
Most effective treatment according to Project MATCH in patients with low psychiatric comorbidity
Twelve step programme